Item 5. Other Information
Item 5. Other Information
Rule 10b5-1 Trading Arrangements
On November 7, 2025 , Luke Scrivanich , Senior Vice President, General Manager OSP of VIAVI, entered into a prearranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of an indeterminable number of shares of common stock. Mr. Scrivanich’s plan begins on November 7, 2025, and expires when all of the shares are sold or on September 16, 2026 , whichever occurs first. The earliest date that sales could occur under this plan is August 31, 2026.
None of VIAVI’s other directors or Section 16 officers adopted , modified or terminated a trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a “non-Rule” 10b5–1 trading arrangement, as those terms are defined in Regulation S-K, Item 408, during the fiscal quarter ended December 27, 2025.
70
Table of Contents
Item 6. Exhibits
The exhibits required to be filed herewith by Item 601 of Regulation S-K, as described in the following index of exhibits, are attached hereto unless otherwise indicated as being incorporated by reference, as follows:
Incorporated by Reference Filed Furnished
Exhibit No. Exhibit Description Form Exhibit Filing Date Herewith Not Filed
31.1
Certification of the Chief Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
31.2
Certification of the Chief Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
X
32.1
Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
32.2
Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
3.1
Amended and Rest ated Certificate of Incorporation
8-K 3.1 11/18/2025
10.1
Viavi Solutions Inc. Equity Incentive Plan, as amended effective November 12, 2025.
X
10.2
Term Loan Credit Agreement, dated as of October 16, 2025 by and among Viavi Solutions Inc., the lenders party thereto and Wells Fargo Bank, National Association as agent
10-Q 10.1 10/30/2025
10.3
Amendment No. 4 dated as of October 16, 2025 to Credit Agreement, dated as of December 30, 2021, among Viavi Solutions Inc. and certain of its subsidiaries, the lenders party thereto and Wells Fargo Bank, National Association, as agent
10-Q 10.2 10/30/2025
10.4
Non-Employee Director Payment Policy, amended as of November 5, 2024
10-Q 10.3 10/30/2025
10.5
Form of Exchange Agreement
8-K 10.1 12/16/2025
101.SCH Inline XBRL Taxonomy Extension Schema X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document X
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document X
104 Cover Page Interactive Data File - (formatted as Inline XBRL and contained in Exhibit 101)
X
71
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: January 29, 2026 VIAVI SOLUTIONS INC.
(Registrant)
By: /s/ ILAN DASKAL
Name: ILAN DASKAL
Title: Executive Vice President and Chief Financial Officer
(Duly Authorized Officer and Principal Financial and Accounting Officer)
72
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.